Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Conmed Corp (NASDAQ:CNMD) and Becton Dickinson (NYSE:BDX).
Conmed Corp (CNMD)
In a report released yesterday, Matthew O’Brien from Piper Jaffray reiterated a Hold rating on Conmed Corp, with a price target of $74. The company’s shares opened today at $77.50.
According to TipRanks.com, O’Brien is a top 25 analyst with an average return of 27.4% and a 72.6% success rate. O’Brien covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Merit Medical Systems.
Currently, the analyst consensus on Conmed Corp is a Moderate Buy with an average price target of $78.50.
See today’s analyst top recommended stocks >>
Becton Dickinson (BDX)
In a report released today, William Quirk from Piper Jaffray reiterated a Buy rating on Becton Dickinson, with a price target of $257. The company’s shares opened today at $245.92, close to its 52-week high of $252.74.
According to TipRanks.com, Quirk is a 5-star analyst with an average return of 17.9% and a 67.9% success rate. Quirk covers the Healthcare sector, focusing on stocks such as Accelerate Diagnostics, Idexx Laboratories, and Myriad Genetics.
Becton Dickinson has an analyst consensus of Moderate Buy, with a price target consensus of $264.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
